Eva K Fenwick1,2,3, Ryan E K Man2, Gwyn Rees1, Jill Keeffe1, Tien Y Wong1,2,4,3, Ecosse L Lamoureux5,6,7. 1. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Parkville, Australia. 2. Singapore Eye Research Institute, Singapore, Singapore. 3. Duke-NUS Medical School, National University of Singapore, 20 College Road Level 6, Singapore, 169856, Singapore. 4. Department of Ophthalmology, National University of Singapore and National University Health System, Singapore, Singapore. 5. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Parkville, Australia. ecosse.lamoureux@duke-nus.edu.sg. 6. Singapore Eye Research Institute, Singapore, Singapore. ecosse.lamoureux@duke-nus.edu.sg. 7. Duke-NUS Medical School, National University of Singapore, 20 College Road Level 6, Singapore, 169856, Singapore. ecosse.lamoureux@duke-nus.edu.sg.
Abstract
PURPOSE: To develop a psychometrically sound and valid Brief Impact of Vision Impairment (IVI) questionnaire. METHODS: Cross-sectional data from four prospective studies (2001-2008) were pooled and randomly divided into development/validation sets (n = 416) each. Items with suboptimal psychometric properties were iteratively removed in the development set to form the Brief IVI. Psychometric properties of the Brief IVI were independently tested in the validation sample. Correlation between person measures from the original and Brief IVI was assessed [Pearson r and intraclass correlation coefficient (ICC)]. Criterion validity was determined by testing the Brief IVI's ability to discriminate levels of vision impairment (analysis of variance, ANOVA). Responsiveness was tested by comparing the ICC of the original and Brief IVI data obtained pre-/post-intervention. RESULTS: The 15-item Brief IVI, and its 9-item Visual Functioning and 6-item Emotional Well-being subscales had ordered thresholds, good precision and targeting, unidimensionality, and minimal item misfit (replicated in the validation sample). Brief and original IVI person measures were highly correlated (r = 0.97 and ICC = 0.98, p < 0.001), indicating the Brief IVI provides statistically similar measurement of vision-related quality of life (VRQoL). Brief IVI mean logit scores declined as vision impairment worsened (p = 0.001) demonstrating criterion validity. ICC of the original versus Brief IVI pre-/post-intervention was excellent (0.98), establishing that the Brief IVI was as responsive to changes in VRQoL as the original. CONCLUSIONS: The Brief 15-item IVI can obtain valid and responsive measurement of VRQoL with half the items in the original and has potential to reduce respondent burden in QoL studies.
PURPOSE: To develop a psychometrically sound and valid Brief Impact of Vision Impairment (IVI) questionnaire. METHODS: Cross-sectional data from four prospective studies (2001-2008) were pooled and randomly divided into development/validation sets (n = 416) each. Items with suboptimal psychometric properties were iteratively removed in the development set to form the Brief IVI. Psychometric properties of the Brief IVI were independently tested in the validation sample. Correlation between person measures from the original and Brief IVI was assessed [Pearson r and intraclass correlation coefficient (ICC)]. Criterion validity was determined by testing the Brief IVI's ability to discriminate levels of vision impairment (analysis of variance, ANOVA). Responsiveness was tested by comparing the ICC of the original and Brief IVI data obtained pre-/post-intervention. RESULTS: The 15-item Brief IVI, and its 9-item Visual Functioning and 6-item Emotional Well-being subscales had ordered thresholds, good precision and targeting, unidimensionality, and minimal item misfit (replicated in the validation sample). Brief and original IVI person measures were highly correlated (r = 0.97 and ICC = 0.98, p < 0.001), indicating the Brief IVI provides statistically similar measurement of vision-related quality of life (VRQoL). Brief IVI mean logit scores declined as vision impairment worsened (p = 0.001) demonstrating criterion validity. ICC of the original versus Brief IVI pre-/post-intervention was excellent (0.98), establishing that the Brief IVI was as responsive to changes in VRQoL as the original. CONCLUSIONS: The Brief 15-item IVI can obtain valid and responsive measurement of VRQoL with half the items in the original and has potential to reduce respondent burden in QoL studies.
Authors: Ecosse L Lamoureux; Julie F Pallant; Konrad Pesudovs; Gwyn Rees; Jennifer B Hassell; Jill E Keeffe Journal: Invest Ophthalmol Vis Sci Date: 2007-04 Impact factor: 4.799
Authors: Ecosse L Lamoureux; Julie F Pallant; Konrad Pesudovs; Gwyn Rees; Jennifer B Hassell; Jill E Keeffe Journal: Invest Ophthalmol Vis Sci Date: 2007-03 Impact factor: 4.799
Authors: S K West; B Munoz; G S Rubin; O D Schein; K Bandeen-Roche; S Zeger; S German; L P Fried Journal: Invest Ophthalmol Vis Sci Date: 1997-01 Impact factor: 4.799
Authors: Ecosse L Lamoureux; Julie F Pallant; Konrad Pesudovs; Alan Tennant; Gwyn Rees; Patricia M O'Connor; Jill E Keeffe Journal: Ophthalmic Epidemiol Date: 2008 Mar-Apr Impact factor: 1.648
Authors: Eva K Fenwick; Bao Sheng Loe; Jyoti Khadka; Ryan E K Man; Gwyn Rees; Ecosse L Lamoureux Journal: Qual Life Res Date: 2019-11-09 Impact factor: 4.147
Authors: Myra B McGuinness; Robert P Finger; Zhichao Wu; Chi D Luu; Fred K Chen; Jenifer J Arnold; Usha Chakravarthy; Wilson J Heriot; Jim Runciman; Robyn H Guymer Journal: Transl Vis Sci Technol Date: 2019-09-11 Impact factor: 3.283